-
iShares U.S. Healthcare Providers ETF (IHF $43.75)
- $43.75 P/E (TTM): 39.48X Cap: $570M
- View IHF Profile
- View Questions on IHF
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
iShares U.S. Healthcare Providers ETF (IHF $43.75)
- $43.75 P/E (TTM): 39.48X Cap: $570M
- View IHF Profile
- View Questions on IHF
-
Elevance Health Inc. (ELV $296.60)
- $296.60 P/E (TTM): 10.96X Cap: $66.78B
- View ELV Profile
- View Questions on ELV
Q: On Oct 22, concerning ELV's quarterly results, you said, "a key issue was the 'timing mismatch' between Medicaid reimbursement rates and the higher healthcare needs of members" - an issue linked to post-COVID resumption of full-service healthcare.
But isn't this a case of 'one-off' cyclicality in an industry which was assumed to be secular? In which case, doesn't ELV become mis-priced as reimbursements and higher needs fall back into balance?
Finally, to operationalize this strategy, would it be preferable to seek-out the most beaten-down health insurer (perhaps you have suggestions), or to pick something like IHF (ditto)?
But isn't this a case of 'one-off' cyclicality in an industry which was assumed to be secular? In which case, doesn't ELV become mis-priced as reimbursements and higher needs fall back into balance?
Finally, to operationalize this strategy, would it be preferable to seek-out the most beaten-down health insurer (perhaps you have suggestions), or to pick something like IHF (ditto)?
-
AbbVie Inc. (ABBV $190.55)
- $190.55 P/E (TTM): 79.96X Cap: $336.58B
- View ABBV Profile
- View Questions on ABBV
-
Johnson & Johnson (JNJ $169.10)
- $169.10 P/E (TTM): 18.68X Cap: $406.86B
- View JNJ Profile
- View Questions on JNJ
-
Eli Lilly and Company (LLY $798.89)
- $798.89 P/E (TTM): 63.18X Cap: $757.13B
- View LLY Profile
- View Questions on LLY
-
Thermo Fisher Scientific Inc (TMO $466.71)
- $466.71 P/E (TTM): 25.08X Cap: $176.18B
- View TMO Profile
- View Questions on TMO
-
UnitedHealth Group Incorporated (DE) (UNH $292.51)
- $292.51 P/E (TTM): 11.94X Cap: $265.34B
- View UNH Profile
- View Questions on UNH
-
Novo Nordisk A/S (NVO $70.03)
- $70.03 P/E (TTM): 18.84X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
-
iShares U.S. Medical Devices ETF (IHI $61.13)
- $61.13 P/E (TTM): 105.73X Cap: $4.38B
- View IHI Profile
- View Questions on IHI
-
iShares U.S. Healthcare Providers ETF (IHF $43.75)
- $43.75 P/E (TTM): 39.48X Cap: $570M
- View IHF Profile
- View Questions on IHF
Q: Hi,
I would like to put some money in US healthcare. What do you think of these ideas?Would you pick one or a couple?
I would like to put some money in US healthcare. What do you think of these ideas?Would you pick one or a couple?
Insiders
Share Information
SEC Filings
News and Media